Project Grant W81XWH2211097
Award Date
9/30/22
Completion Date
9/29/25
Dollars Obligated
$492K
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Great Britain, United Kingdom
Similar Awards
The Department of the Army Medical Command awarded a $699,534 project grant to the Institute of Cancer Research: Royal Cancer Hospital under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will support research on B7-H3 (CD276) as a therapeutic target in lethal prostate cancers. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research that investigates medical solutions...
The Department of the Army Medical Command awarded Ospedale San Raffaele S.R.L. a $650,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 30, 2022 to September 29, 2025 to engineer thymic selection to control the development of alloreactive T cells and promote vascularized composite allograft acceptance. The Military Medical Research and Development program aims to transform military and public health...
The Department of the Army Medical Command awarded a $539,979 project grant to Imperial College London under the Military Medical Research and Development program. The grant will fund research from August 2021 to August 2024 to develop a monoclonal antibody targeting CXCL13 to promote axonal plasticity, regeneration, and functional recovery after spinal cord injury. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The Department of the Army Medical Command awarded Monash University a $1,498,168 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Targeted Regulatory T Cells to Treat SLE from September 1, 2022 through August 31, 2025. Under this award, Monash University will conduct research to investigate medical solutions for systemic lupus erythematosus (SLE) by developing targeted regulatory T cells as an innovative treatment approach. The...
The Department of the Army Medical Command awarded a $1,248,949 Project Grant to Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research into stable mixed chimerism and tolerance of vascularized composite allografts via BCL-2 inhibition from September 30, 2022 to August 31, 2025.
The Military Medical Research and Development program supports innovative biomedical research with the goals of improving military and public health...
The Department of the Army Medical Command awarded a $693,513 Project Grant to Brigham & Women's Hospital Inc. through the Military Medical Research and Development program. The grant will fund research into the molecular mechanisms of therapy-related myeloid neoplasms from September 30, 2022 to September 29, 2025.
As the stated purpose of the Military Medical Research and Development program is to transform military and public health through innovative medical research solutions, this...
The Department of the Army Medical Command awarded a $519,702 Project Grant to Stanford University under the Military Medical Research and Development program (CFDA 12.420). The two-year grant will support Stanford's development of non-genotoxic hematopoietic stem cell transplantation regimens for Fanconi anemia. Fanconi anemia is a rare genetic disorder that can cause bone marrow failure and blood cancers. The Military Medical Research and Development program aims to advance medical...
The Department of the Army Medical Command awarded a $162,000 project grant to The Trustees of Columbia University in New York, NY under the Military Medical Research and Development program. The grant supports the development of amyloid fibril-specific chimeric antigen receptor macrophages (CAR-M)-based immunotherapy for amyloid clearance in light chain amyloidosis from August 1, 2021 through July 31, 2023. The Military Medical Research and Development program (CFDA 12.420) aims to conduct...
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public....
The Department of the Army Medical Command awarded a $744,224 Project Grant to Health Research, Inc. Roswell Park Division under the Military Medical Research and Development program. The grant will fund research from September 2022 through September 2025 to activate anti-myelodysplastic syndrome immunity through restoration of the immune microenvironment.
The Military Medical Research and Development program supports innovative biomedical research with the goals of improving military and...